Wright Medical Group N.V. (WMGI2)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Lance A. Berry
Employees:
2,874
PRINS BERNHARDPLEIN 200, AMSTERDAM, NETHERLANDS 1097JB
901-867-4317

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells orthopedic products in the United States, Europe, and internationally.

Data derived from most recent annual or quarterly report
Market Cap 3.888 Billion Shares Outstanding129.684 Million Avg 30-day Volume 1.632 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.15
Price to Revenue4.2741 Debt to Equity1.3098 EBITDA152.214 Million
Price to Book Value4.4136 Operating Margin1.2582 Enterprise Value4.937 Billion
Current Ratio0.875 EPS Growth0.404 Quick Ratio0.37
1 Yr BETA 0.2808 52-week High/Low 0.0 / Profit Margin-12.4036
Operating Cash Flow Growth165.2874 Altman Z-Score0.7869 Free Cash Flow to Firm -28.62 Million
View SEC Filings from WMGI2 instead.

View recent insider trading info

Funds Holding WMGI2 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding WMGI2

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2020-11-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-04-27:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-08:
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-05:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2019-01-31:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2018-12-14:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-10:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PALMISANO ROBERT J PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2020-11-11 0

    BLACKFORD GARY

    • Director
    No longer subject to file 2020-11-11 0

    MICLOT JOHN L

    • Director
    No longer subject to file 2020-11-11 0

    WEATHERMAN ELIZABETH H

    • Director
    No longer subject to file 2020-11-11 0

    WALLMAN RICHARD F

    • Director
    No longer subject to file 2020-11-11 0

    OBOYLE KEVIN C

    • Director
    No longer subject to file 2020-11-11 0

    DEWEY JULIE D. SVP, CHIEF COMMUNICATIONS OFR

    • Officer
    No longer subject to file 2020-11-11 0

    PAUL AMY S

    • Director
    No longer subject to file 2020-11-11 0

    STEVENS DAVID D

    • Director
    No longer subject to file 2020-11-11 0

    LIGHTMAN JAMES SVP, GENERAL COUNSEL & SEC

    • Officer
    No longer subject to file 2020-11-11 0

    CORDELL KEVIN D EVP, CHIEF GLOBAL COMM OFFICER

    • Officer
    No longer subject to file 2020-11-11 0

    MACKIN JAMES P

    • Director
    No longer subject to file 2020-11-11 0

    BERRY LANCE A EVP, CHIEF FIN & OP OFFICER

    • Officer
    No longer subject to file 2020-11-11 0

    WRIGHT MEDICAL GROUP N.V. PRESIDENT, LOWER EXTREMITIES

    • Officer
    No longer subject to file 2020-11-11 0

    MORTON ANDREW C. SVP, CHIEF HUMAN RESOURCES OFR

    • Officer
    No longer subject to file 2020-11-11 0

    WALKER JENNIFER S. SVP, PROCESS IMPROVEMENT

    • Officer
    No longer subject to file 2020-11-11 0

    ANDREWS JULIE SVP, GLOBAL FINANCE

    • Officer
    No longer subject to file 2020-11-11 0

    COOKE PETER PRES, EMERG. MARKETS, AUSJAPAN

    • Officer
    No longer subject to file 2020-11-11 0

    PORTER JONATHAN WESLEY SVP, CHIEF COMPLIANCE OFFICER

    • Officer
    No longer subject to file 2020-11-11 0

    FISHER PATRICK PRESIDENT, LOWER EXTREMITIES

    • Officer
    No longer subject to file 2020-11-11 0

    LANIER TIM PRESIDENT, UPPER EXTREMITIES

    • Officer
    No longer subject to file 2020-11-11 0

    ASPER JASON D. SVP, CHIEF DIGITAL OFFICER

    • Officer
    No longer subject to file 2020-11-11 0

    SMITH KEVIN C. SVP, QUALITY AND REGULATORY

    • Officer
    No longer subject to file 2020-11-11 0

    REGAN BARRY J. SVP, OPERATIONS

    • Officer
    No longer subject to file 2020-11-11 0

    WALLACE STEVEN P. PRESIDENT, INTERNATIONAL

    • Officer
    No longer subject to file 2020-11-11 0

    BURROWS ROBERT P. III SVP, SUPPLY CHAIN

    • Officer
    67,984 2018-06-04 0

    MORRISON GREGORY SVP, HUMAN RESOURCES

    • Officer
    35,488 2017-11-10 0

    CARNEY SEAN

    • Director
    9,283 2017-03-31 0

    GRIFFIN WILLIAM L. JR SR. VP & GM, BIOMIMETIC

    • Officer
    85,490 2016-07-19 0

    RICH TERRY PRESIDENT, UPPER EXTREMITIES

    • Officer
    59,972 2016-06-02 0

    MOWRY DAVID H EXECUTIVE VP AND COO

    • Officer
    • Director
    160,311 2016-03-07 0

    TMG HOLDINGS COOPERATIEF U.A.

    WARBURG PINCUS (BERMUDA) PRIVATE EQUITY IX, L.P.

    WP (BERMUDA) IX PE ONE LTD.

    WARBURG PINCUS (BERMUDA) PRIVATE EQUITY LTD.

    WARBURG PINCUS LLC

    KAYE CHARLES R

    LANDY JOSEPH P.

    • Director
    • 10% Owner
    No longer subject to file 2015-11-23 0

    EMMITT RICHARD B

    • Director
    No longer subject to file 2015-10-01 0

    KLEMZ KEVIN M SR. VP, CLO AND SECRETARY

    • Officer
    No longer subject to file 2015-10-01 0

    MCCORMICK SHAWN CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2015-10-01 0

    TORNIER ALAIN

    • Director
    No longer subject to file 2015-10-01 0

    VAN UMMERSEN GORDON SR. VP, PRODUCT DELIVERY

    • Officer
    No longer subject to file 2015-10-01 0

    EPINETTE STEPHAN VP INT'L COMMERCIAL OPERATIONS

    • Officer
    35,310 2015-05-12 0

    WRIGHT MEDICAL GROUP INC

    • 10% Owner
    0 2014-10-27 0

    KOHRS DOUGLAS W PRESIDENT AND CEO

    • Officer
    • Director
    481,723 2012-08-10 0

    GIRIN PASCAL E R

    • Director
    7,171 2012-08-10 0

    DIERSEN CARMEN L GLOBAL CHIEF FINANCIAL OFFICER

    • Officer
    27,420 2011-05-12 0

    JOINER ANDREW VP, GEN. MAN., US COMM. OP.

    • Officer
    8,030 2011-05-12 0

    KWAN JAMES EDWARD VP, GLOBAL SUPPLY CHAIN

    • Officer
    6,654 2011-05-12 0

    KCH STOCKHOLM AB

    • Director
    3,488,262 2011-05-12 0

    BALL JOSEPH ROBERT VP, GLOBAL R&D

    • Officer
    6,190 2011-05-12 0

    VERTICAL GROUP LP

    • 10% Owner
    3,383,101 2011-02-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund WMGI2 -598.0 shares, $-18227.04 2019-12-31 N-PORT
    American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund WMGI2 -20928.0 shares, $-431744.64 2019-09-30 N-PORT
    American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund WMGI2 -62172.0 shares, $-1282608.36 2019-09-30 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund WMGI2 -105.0 shares, $-3206.7 2020-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments